0001209191-23-055436.txt : 20231115 0001209191-23-055436.hdr.sgml : 20231115 20231115201453 ACCESSION NUMBER: 0001209191-23-055436 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231110 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vig Pamela CENTRAL INDEX KEY: 0001780069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 231412175 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-10 0 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001780069 Vig Pamela C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 0 1 0 0 Head of Research & Development 0 Common Stock 2023-11-10 5 A 0 E 527 22.287 A 31313 D Common Stock 75000 I By The Vig-Ancock Family Trust This Form 4 is being filed voluntarily to report the acquisition of 527 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. /s/ Judit Ryvkin, Attorney-in-Fact 2023-11-15